Showing results (1311-1320 of 21,417) with videos related to

Sort By:
Pageof 2,142
The Journal of Experimental Medicine|December 26, 2001
Sialylated O-glycans and sulfated tyrosines in the NH2-terminal domain of CC chemokine receptor 5 contribute to high affinity binding of chemokinesN Bannert, S Craig, M Farzan, et al.
The Journal of Experimental Medicine|December 26, 2001
Cytotoxic T lymphocyte antigen 4 and CD28 modulate cell surface raft expression in their regulation of T cell functionM Martin, H Schneider, A Azouz, et al.
The Journal of Experimental Medicine|December 26, 2001
Hepatocyte nuclear factor 1alpha controls the expression of terminal complement genesM Pontoglio, M Pausa, A Doyen, et al.
The Journal of Experimental Medicine|June 20, 2001
Two waves of nuclear factor kappaB recruitment to target promotersS Saccani, S Pantano, G Natoli
The Journal of Experimental Medicine|June 20, 2001
c-abl is required for the development of hyperoxia-induced retinopathyI Nunes, R D Higgins, L Zanetta, et al.
The Journal of Experimental Medicine|June 20, 2001
Essential requirement for c-kit and common gamma chain in thymocyte development cannot be overruled by enforced expression of Bcl-2H R Rodewald, C Waskow, C Haller
The Journal of Experimental Medicine|March 10, 2001
Lyn is essential for fcgamma receptor III-mediated systemic anaphylaxis but not for the Arthus reactionT Yuasa, M Ono, T Watanabe, et al.
The Journal of Experimental Medicine|March 10, 2001
Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout miceS W Chensue, N W Lukacs, T Y Yang, et al.
The Journal of Experimental Medicine|March 10, 2001
Molecular basis for hematopoietic/mesenchymal interaction during initiation of Peyer's patch organogenesisK Honda, H Nakano, H Yoshida, et al.
The Journal of Experimental Medicine|March 10, 2001
Essential role of nuclear factor (NF)-kappaB-inducing kinase and inhibitor of kappaB (IkappaB) kinase alpha in NF-kappaB activation through lymphotoxin beta receptor, but not through tumor necrosis factor receptor IA Matsushima, T Kaisho, P D Rennert, et al.
Pageof 2,142